178 related articles for article (PubMed ID: 35493608)
1. Pigment Epithelium-Derived Factor-Loaded PEGylated Nanoparticles as a New Antiangiogenic Therapy for Neovascularization.
Zhao F; Fei W; Li Z; Yu H; Xi L
J Diabetes Res; 2022; 2022():1193760. PubMed ID: 35493608
[TBL] [Abstract][Full Text] [Related]
2. Polyethylene glycol-modified pigment epithelial-derived factor: new prospects for treatment of retinal neovascularization.
Bai YJ; Huang LZ; Xu XL; Du W; Zhou AY; Yu WZ; Li XX
J Pharmacol Exp Ther; 2012 Jul; 342(1):131-9. PubMed ID: 22495066
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenesis effects of endostatin in retinal neovascularization.
Bai YJ; Huang LZ; Zhou AY; Zhao M; Yu WZ; Li XX
J Ocul Pharmacol Ther; 2013 Sep; 29(7):619-26. PubMed ID: 23545016
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory effects of a synthetic peptide derived from pigment epithelium-derived factor on H₂O₂-induced corneal injury in vitro.
Lu Y; Feng J; Yang L; Tang H; Jin J; Xu X
Chin Med J (Engl); 2014; 127(8):1438-44. PubMed ID: 24762585
[TBL] [Abstract][Full Text] [Related]
5. Nornicotine and Nicotine Induced Neovascularization via Increased VEGF/PEDF Ratio.
Zhang Y; Ma A; Wang L; Zhao B
Ophthalmic Res; 2015; 55(1):1-9. PubMed ID: 26536586
[TBL] [Abstract][Full Text] [Related]
6. PlGF silencing combined with PEDF overexpression: Modeling RPE secretion as potential therapy for retinal neovascularization.
Araújo RS; Silva GA
Mol Biol Rep; 2020 Jun; 47(6):4413-4425. PubMed ID: 32385771
[TBL] [Abstract][Full Text] [Related]
7. A short peptide derived from pigment epithelial-derived factor exhibits an angioinhibitory effect.
Ho TC; Yeh SI; Chen SL; Chu TW; Tsao YP
BMC Ophthalmol; 2022 Feb; 22(1):88. PubMed ID: 35193548
[TBL] [Abstract][Full Text] [Related]
8. Pigment epithelium-derived factor gene loaded in cRGD-PEG-PEI suppresses colorectal cancer growth by targeting endothelial cells.
Li L; Yang J; Wang WW; Yao YC; Fang SH; Dai ZY; Hong HH; Yang X; Shuai XT; Gao GQ
Int J Pharm; 2012 Nov; 438(1-2):1-10. PubMed ID: 22974524
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic effects and transcriptional regulation of pigment epithelium-derived factor in diabetic retinopathy.
Wang B; Atherton P; Patel R; Manning G; Donnelly R
Microvasc Res; 2010 Jul; 80(1):31-6. PubMed ID: 20219495
[TBL] [Abstract][Full Text] [Related]
10. Pigment epithelial-derived factor gene loaded novel COOH-PEG-PLGA-COOH nanoparticles promoted tumor suppression by systemic administration.
Yu T; Xu B; He L; Xia S; Chen Y; Zeng J; Liu Y; Li S; Tan X; Ren K; Yao S; Song X
Int J Nanomedicine; 2016; 11():743-59. PubMed ID: 26955272
[TBL] [Abstract][Full Text] [Related]
11. The ratio of VEGF/PEDF expression in bone marrow mesenchymal stem cells regulates neovascularization.
Fan W; Crawford R; Xiao Y
Differentiation; 2011 Mar; 81(3):181-91. PubMed ID: 21236558
[TBL] [Abstract][Full Text] [Related]
12. Pigment epithelium-derived factor/vascular endothelial growth factor ratio plays a crucial role in the spontaneous regression of infant hemangioma and in the therapeutic effect of propranolol.
Zhu L; Xie J; Liu Z; Huang Z; Huang M; Yin H; Qi W; Yang Z; Zhou T; Gao G; Zhang J; Yang X
Cancer Sci; 2018 Jun; 109(6):1981-1994. PubMed ID: 29664206
[TBL] [Abstract][Full Text] [Related]
13. Phosphomimetic mutants of pigment epithelium-derived factor with enhanced antiangiogenic activity as potent anticancer agents.
Konson A; Pradeep S; Seger R
Cancer Res; 2010 Aug; 70(15):6247-57. PubMed ID: 20610633
[TBL] [Abstract][Full Text] [Related]
14. Pigment epithelium-derived factor acts as an opponent of growth-stimulatory factors in retinal glial-endothelial cell interactions.
Yafai Y; Lange J; Wiedemann P; Reichenbach A; Eichler W
Glia; 2007 Apr; 55(6):642-51. PubMed ID: 17309061
[TBL] [Abstract][Full Text] [Related]
15. PEDF is an endogenous inhibitor of VEGF-R2 angiogenesis signaling in endothelial cells.
Zhang M; Tombran-Tink J; Yang S; Zhang X; Li X; Barnstable CJ
Exp Eye Res; 2021 Dec; 213():108828. PubMed ID: 34742690
[TBL] [Abstract][Full Text] [Related]
16. Growth suppression of cervical carcinoma by pigment epithelium-derived factor via anti-angiogenesis.
Yang J; Chen S; Huang X; Han J; Wang Q; Shi D; Cheng R; Gao G; Yang X
Cancer Biol Ther; 2010 Jun; 9(12):967-74. PubMed ID: 20364117
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of vascular endothelial growth factor and up-regulation of pigment epithelium derived factor make low molecular weight heparin-endostatin and polyethylene glycol-endostatin potential candidates for anti-angiogenesis drug.
Tan H; Mu G; Zhu W; Liu J; Wang F
Biol Pharm Bull; 2011; 34(4):545-50. PubMed ID: 21467643
[TBL] [Abstract][Full Text] [Related]
18. PEDF derived from glial Müller cells: a possible regulator of retinal angiogenesis.
Eichler W; Yafai Y; Keller T; Wiedemann P; Reichenbach A
Exp Cell Res; 2004 Sep; 299(1):68-78. PubMed ID: 15302574
[TBL] [Abstract][Full Text] [Related]
19. Expression of angiogenesis factors in human umbilical vein endothelial cells and their regulation by PEDF.
Aparicio S; Sawant S; Lara N; Barnstable CJ; Tombran-Tink J
Biochem Biophys Res Commun; 2005 Jan; 326(2):387-94. PubMed ID: 15582590
[TBL] [Abstract][Full Text] [Related]
20. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
